Mahamaya Lifesciences MD & ED Interview Published in AgroPages

Mahamaya Lifesciences Ltd announced the publication of an interview featuring its Managing Director, Mr. Krishnamurthy Ganesan, and Executive Director, Mr. Prashant Krishnamurthy, in the 2026 India Focus Issue of AgroPages magazine. The interview, published in the September 2026 edition, discusses the company's operational progress, strategic growth initiatives, and industry outlook. It highlights the deployment of IPO proceeds towards the Dahej technical manufacturing facility, backward integration, indigenous molecules, and expanding its portfolio of branded and export formulations. The interview also touches upon the company's strategy concerning China+1, India's self-reliance goals, sustainability, and biologicals. Mahamaya Lifesciences, which listed on the BSE SME platform in November 2025, reported FY2025-26 revenue of Rs. 328.87 crore, a 24.5% increase. The IPO proceeds are primarily allocated to the Dahej facility, formulation and warehouse infrastructure, and working capital, strengthening the company's balance sheet with a net debt-to-equity ratio improving from 1.18x to 0.74x.